Recruitment is underway for a clinical trial testing a vaccine candidate produced with The University of Queensland's molecular clamp technology against life-threatening respiratory viruses.

Moderna says Health Canada has approved its mRNA vaccine to protect against respiratory syncytial virus in adults age 60 and ...

The other group at the highest risk when it comes to RSV is children under age five, and specifically infants—especially ...

Last year was the first year that the US had vaccines available to protect against all three major respiratory viruses — Covid-19, flu and RSV — but vaccine uptake was low for the season. “Our top ...

Vaccine effectiveness was 73 percent against associated hospitalizations among 8,435 ... “These findings provide additional context regarding the benefit of respiratory syncytial virus vaccination ...

with affordable access to the vaccine against respiratory syncytial virus (RSV). RSV is a leading cause of paediatric hospitalisation and death from respiratory infections during the first six ...

Is the Australian flu dangerous for the brain? This new flu variant, along with RSV, Covid, and pneumococcal pneumonia, are ...

STARTING in the first quarter of 2025, the Pan American Health Organization (PAHO), through its Regional Revolving Funds, will provide countries of the ...

Is the Australian flu dangerous for the brain? This new flu variant, along with RSV, Covid, and pneumococcal pneumonia, are ...

As Mississippi approaches what is historically the respiratory virus season, the Mississippi State Department of Health (MSDH ...